세계의 AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 지원 시장 보고서(2025년)
Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Global Market Report 2025
상품코드 : 1877502
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,718,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,710,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,703,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 지원 시장 규모는 최근 급격하게 확대하고 있습니다. 2024년 13억 1,000만 달러에서 2025년에는 16억 1,000만 달러로 확대되고, CAGR 23.5%로 성장이 전망되고 있습니다. 이 성장은 만성 호흡기 질환의 유병률 증가, ICU 입원 환자 증가, 환자 개별 최적화된 인공호흡 전략의 긴급성, 더 나은 치료 결과에 대한 수요 증가, 원격 의료 및 원격 모니터링의 보급 확대 등의 요인으로 인한 것으로 예측됩니다.

AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 지원 시장 규모는 향후 수년간 급격한 성장이 예상됩니다. 2029년까지 37억 1,000만 달러에 달하고, CAGR은 23.2%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 개별화된 효율적인 환자 관리에 대한 수요 증가, 의료 인프라 투자 확대, 호흡기 질환을 앓고 있는 노인 인구 증가, 효율화 솔루션을 추진하는 의료비 상승, 지속적인 환자 모니터링의 필요성 등이 있습니다. 예측기간의 주요 동향으로는 집중치료 분야에 AI 통합, 머신러닝 알고리즘의 진보, AI 기반의 의사결정 지원 시스템의 개발, 실시간 모니터링과 예측 분석, 강화 학습과 임상 데이터를 조합한 하이브리드 AI 모델의 창출 등을 들 수 있습니다.

호흡기 질환의 유병률 상승은 향후 수년간 AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 지원 시장의 성장을 견인할 것으로 예측됩니다. 호흡기 질환은 폐와 기도에 영향을 미치고 정상적인 호흡과 산소 교환을 방해하는 병입니다. 선진국의 고령화에 따라 면역기능의 저하와 환경 노출의 누적에 의해 고령자가 만성 호흡기 질환에 걸리기 쉬워지고 있기 때문에 유병률은 증가 경향에 있습니다. AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 지원 시스템은 환자 고유의 데이터를 지속적으로 분석하고 최적의 이탈 시기를 예측함으로써 인공호흡기 사용기간 단축, 합병증 최소화, 환자 결과를 개선하는 개별화된 시기 적절한 임상개입을 가능하게 하고 호흡기 질환 관리를 지원합니다. 예를 들어 호주 보건복지 연구소(AIHW) 2024년 6월 발표에 따르면 2023년 만성폐쇄성 폐질환(COPD)은 호주의 질병 부담 총량의 3.6%를 차지하며 호흡기 질환 전체의 부담의 절반을 차지했습니다. 따라서 호흡기 질환 증가 추세는 AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 시장의 성장을 가속하고 있습니다.

맞춤형 의료에 대한 관심 증가는 향후 수년간 AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 지원 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료는 환자의 유전자 프로파일, 생활 습관, 환경 요인에 따라 치료 및 의료 판단을 개별적으로 최적화하는 접근법입니다. 유전체 기술과 데이터 분석의 진보로 중요한 의료 현장에서 보다 정밀하고 개별화된 케어가 가능해지고 그 채용이 확대되고 있습니다. AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 지원 시스템은 개별 환자 데이터를 분석하여 인공호흡기 이탈의 최적 타이밍을 판단하고 맞춤형 치료 프로토콜을 통해 환자 결과를 개선함으로써 맞춤형 의료를 지원합니다. 예를 들어, 2024년 2월에 개인 맞춤형 의료 연합이 발표한 바에 의하면, FDA는 2023년에 희귀질환 환자를 위한 신규 맞춤형 치료를 16건 승인했습니다. 이것은 2022년 6건에서 10건 증가한 수치입니다. 이와 같이 맞춤형 의료에 대한 주목이 높아지고 있는 것이, AI 활용 집중치료실(ICU) 환자 인공호흡기 이탈 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning refers to the use of AI-driven algorithms to support the gradual reduction and eventual discontinuation of mechanical ventilation in critically ill patients. It utilizes real-time patient data to predict readiness for weaning, optimize ventilator settings, and minimize complications. This approach aims to improve patient outcomes, shorten the duration of ventilation, and reduce ICU-related risks.

The primary components of AI-enhanced ICU ventilation weaning include software, hardware, and services. Software consists of programs and algorithms that enable computers to perform tasks, analyze data, and provide actionable insights. These solutions can be deployed on-premises or via the cloud and are applied in adult, pediatric, and neonatal intensive care units. They serve a range of end-users, including hospitals, specialty clinics, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market statistics, including artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning industry global market size, regional shares, competitors with the artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market share, artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning industry. This artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market size has grown exponentially in recent years. It will grow from $1.31 billion in 2024 to $1.61 billion in 2025 at a compound annual growth rate (CAGR) of 23.5%. The growth during the historic period can be attributed to the rising prevalence of chronic respiratory diseases, increasing ICU admissions, the urgent need for optimized patient-specific ventilation strategies, growing demand for better patient outcomes, and expanding adoption of telemedicine and remote monitoring.

The artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market size is expected to see exponential growth in the next few years. It will grow to $3.71 billion in 2029 at a compound annual growth rate (CAGR) of 23.2%. The growth during the forecast period can be attributed to the rising demand for personalized and efficient patient care, increasing investments in healthcare infrastructure, a growing geriatric population with respiratory conditions, rising healthcare costs driving efficiency solutions, and the need for continuous patient monitoring. Key trends in the forecast period include the integration of AI in critical care, advancements in machine learning algorithms, development of AI-based decision support systems, real-time monitoring and predictive analytics, and the creation of hybrid AI models that combine reinforcement learning with clinical data.

The rising prevalence of respiratory diseases is expected to drive the growth of the artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market in the coming years. Respiratory diseases are conditions that affect the lungs and airways, impairing normal breathing and oxygen exchange. Their prevalence is increasing due to aging populations in developed nations, as older adults are more susceptible to chronic respiratory conditions because of weakened immune systems and cumulative environmental exposures. AI-enhanced ICU ventilation weaning supports the management of respiratory diseases by continuously analyzing patient-specific data, predicting optimal weaning times, reducing the duration of mechanical ventilation, minimizing complications, and enabling personalized, timely clinical interventions that improve patient outcomes. For example, in June 2024, according to the Australian Institute of Health and Welfare, in 2023 chronic obstructive pulmonary disease accounted for 3.6 percent of Australia's total disease burden and represented half of the overall burden from respiratory conditions. Therefore, the rising prevalence of respiratory diseases is fueling the growth of the AI-enhanced ICU ventilation weaning market.

The growing emphasis on personalized medicine is expected to propel the growth of the AI-enhanced ICU ventilation weaning market in the coming years. Personalized medicine is an approach that tailors treatment and healthcare decisions to individual patients based on their genetic profile, lifestyle, and environmental factors. Its adoption is increasing due to advances in genomic technologies and data analytics, which enable more precise and individualized care across critical healthcare settings. AI-enhanced ventilation weaning systems support personalized medicine by analyzing individual patient data to determine optimal timing for mechanical ventilation removal, improving patient outcomes through customized treatment protocols. For instance, in February 2024, according to the Personalized Medicine Coalition, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, up from six in 2022, reflecting a rise of ten new approvals. Therefore, the growing focus on personalized medicine is driving the growth of the AI-enhanced ICU ventilation weaning market.

In October 2025, Etiometry Inc., a US-based software company specializing in AI-enhanced solutions for ventilator weaning in the ICU, partnered with Hospinorm FZCO to introduce its AI-driven platform in the UAE. Through this partnership, Hospinorm and Etiometry aim to bring FDA-cleared clinical decision-support technology to the region, providing clinicians with real-time insights, improving patient outcomes, and elevating critical care standards. The platform enables early detection of patient deterioration, standardizes care protocols, and optimizes resource utilization in intensive care units. Hospinorm FZCO is a UAE-based healthcare technology company focused on providing advanced medical solutions and innovative healthcare technologies.

Major players in the artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market are Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Dragerwerk AG & Co. KGaA, Getinge AB, Nihon Kohden Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Hicuity Health Inc., Hospinorm Healthcare Pvt. Ltd., Clinomic (Mona) Ltd., Piramidal Technologies Ltd., Deep Breath Ltd., AgVa Healthcare Pvt. Ltd., Etiometry Inc., Clew Medical Ltd., AiiNTENSE Inc., Ambient Clinical Analytics Inc., Aerobiosys Innovations Pvt. Ltd., Caliber Interconnect Solutions Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market consists of revenues earned by entities by providing services such as clinician decision support systems, remote monitoring and tele-ICU services, predictive analytics and risk assessment, workflow optimization solutions, training and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced intensive care unit (ICU) ventilation weaning market also includes sales of ventilator monitoring systems, telerobotic ventilator controllers, and wearable respiratory sensors, and non-invasive ventilation (NIV) devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-enhanced intensive care unit (icu) ventilation weaning market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced intensive care unit (icu) ventilation weaning ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced intensive care unit (icu) ventilation weaning market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market Characteristics

3. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market Trends And Strategies

4. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Growth Analysis And Strategic Analysis Framework

6. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market Segmentation

7. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market Regional And Country Analysis

8. Asia-Pacific Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

9. China Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

10. India Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

11. Japan Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

12. Australia Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

13. Indonesia Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

14. South Korea Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

15. Western Europe Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

16. UK Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

17. Germany Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

18. France Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

19. Italy Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

20. Spain Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

21. Eastern Europe Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

22. Russia Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

23. North America Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

24. USA Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

25. Canada Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

26. South America Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

27. Brazil Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

28. Middle East Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

29. Africa Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

30. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market Competitive Landscape And Company Profiles

31. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market Other Major And Innovative Companies

32. Global Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

34. Recent Developments In The Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market

35. Artificial Intelligence (AI)-Enhanced Intensive Care Unit (ICU) Ventilation Weaning Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기